Analyst	Recommendation	Action	Price target	Projected	Date
Ram Selvaraju H.C. Wainwright	Buy	Reiterated	$16.00	+277.4%	11/09/2026
Unknown Analyst Oppenheimer	Buy	Maintained	$10.00	+135.8%	11/06/2026
Edward Nash Canaccord Genuity	Buy	Reiterated	$13.00	+206.6%	11/06/2026
Martin Fan Wedbush	Buy	Maintained	$8.00	+88.7%	11/06/2026
Seamus Fernandez Guggenheim	Buy	Reiterated	$12.00	+183%	10/28/2026
Adam Vogel Craig-Hallum	Buy	Maintained	$9.00	+112.3%	10/28/2026
Biren Amin Piper Sandler	Buy	Maintained	$11.00	+159.4%	10/19/2026
Kate Dellorusso LifeSci Capital	Buy	Maintained	$13.00	+206.6%	10/01/2026
Jeff Jones Oppenheimer	Buy	Reiterated	$10.00	+135.8%	05/08/2026
Alex Thompson CFA Stifel Nicolaus	Hold	Maintained	$4.00	-5.7%	05/08/2026
Unknown Analyst Goldman Sachs	Buy	Maintained	$10.00	+135.8%	04/16/2026

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	1.30M	2.00M	1.63M	1.48M
Cost of goods sold	18.05M	17.44M	19.52M	17.39M
Cost of revenue	18.05M	17.44M	19.52M	17.39M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.58M	6.74M	6.05M	6.04M
Operating expense	5.58M	6.74M	6.05M	6.04M
Total operating expenses	23.63M	24.19M	25.57M	23.42M
Operating income	-22.33M	-22.19M	-23.94M	-21.94M
Other non operating income	1.30M	854.00K	972.00K	985.00K
EBT including unusual items	-19.80M	-19.82M	-21.50M	-18.51M
EBT excluding unusual items	-19.40M	-19.82M	-21.20M	-19.11M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-19.80M	-19.82M	-21.50M	-18.51M
Net profit margin	-1,528.57%	-993.19%	-1,320.13%	-1,249.83%
Earnings per share	-0.16	-0.15	-0.15	-
Interest and investment income	1.63M	1.51M	1.76M	1.85M
Interest expense	-	-	-	-
Net interest expenses	1.63M	1.51M	1.76M	1.85M
Depreciation and amortization charges	-	-	-	-
EBITDA	-22.32M	-22.19M	-23.94M	-
Gain or loss from assets sale	-	-	-	-

Ask anything